Stockscreener 앱 받기
114.23
1.61%
1.81
전일 마감가:
$112.42
열려 있는:
$112.64
하루 거래량:
9.92M
Relative Volume:
2.11
시가총액:
$198.13B
수익:
$41.22B
순이익/손실:
$5.77B
주가수익비율:
38.85
EPS:
2.94
순현금흐름:
$6.49B
1주 성능:
+0.75%
1개월 성능:
-1.47%
6개월 성능:
+7.19%
1년 성능:
+6.36%
1일 변동 폭
$112.52
$115.11
1주일 범위
$111.28
$115.11
52주 변동 폭
$99.71
$121.64
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
M&T Bank Corp Has $110.42 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline - Seeking Alpha
Abbott Whistleblower's False Claims Suit is Revived, Narrowed - Bloomberg Law
Abbott Labs stock target increased, buy rating on strong product lineup - Investing.com
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Yahoo Finance
XTX Topco Ltd Sells 31,480 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott announces “first-in-world” leadless pacing procedures in left bundle branch area of heart - Cardiac Rhythm News
Implantable Loop Recorder Market Top Companies StudyAbbott - openPR
Syntax Research Inc. Makes New $2.28 Million Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
The Smartest Dividend Stocks to Buy With $500 Right Now - The Motley Fool
Biochips Market Huge Growth in Future Scope 2024-2031 | Abbott - openPR
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker - Cardiovascular Business
Abbott completes first-in-human leadless left bundle branch area pacing procedures - Mass Device
Cardiac Biomarkers Market CAGR of 13.3% Size, Current Trends, Future Prospects By 2024-2031 | Abbott - EIN News
Are Abbott Laboratories' (NYSE:ABT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart - The Eastern Progress Online
Abbott Laboratories (ABT-N) QuotePress Release - The Globe and Mail
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
How Abbott Labs Became a Dividend Growth Investor's Dream - MSN
How Abbott Labs Became A Dividend Growth Investor's Dream - Barchart
Abbott Laboratories a Top Ranked SAFE Dividend Stock With 2.1% Yield (ABT) - Nasdaq
Abbott Laboratories' SWOT analysis: medtech giant's stock faces litigation hurdles - Investing.com
Possible Bearish Signals With Abbott Laboratories Insiders Disposing Stock - Simply Wall St
B. Riley Wealth Advisors Inc. Sells 11,409 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Copley Financial Group Inc. Purchases New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Retirement Systems of Alabama - MarketBeat
Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch
Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns - Yahoo Finance
Abbott boosts quarterly dividend to 59 cents, up 7.3% - Investing.com
Abbott Declares Quarterly Common Dividend, Payable February 14, 2025 - Marketscreener.com
Abbott Labs Extends Royal Dividend Run With 7.3% Increase - Marketscreener.com
Abbott Increases Quarterly Dividend for 53rd Consecutive Year - The Eastern Progress Online
NEC Baby Formula Lawsuit - Lawsuit Information Center Blog
Tidal Investments LLC Purchases 25,052 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Franklin Resources Inc. Has $1.14 Billion Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott - Life Sciences Intellectual Property Review
Stock Yards Bank & Trust Co. Has $38.17 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Dexcom suffers third successive patent loss in Abbott UPC dispute - IAM
Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them - Benzinga
Abbott Laboratories (NYSE:ABT) Shares Acquired by Teachers Retirement System of The State of Kentucky - MarketBeat
Toronto Dominion Bank Sells 220,223 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Groupama Asset Managment Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Baby Nutrition Market Size, Growth Status to 2033 Danone, Abbott - openPR
Lightning Round: Abbott Labs' legal trouble is largely behind it, says Jim Cramer - MSN
Cramer's Lightning Round: 'Keep owning' Energy Transfer - CNBC
Abbott Laboratories (NYSE:ABT) Shares Acquired by Geode Capital Management LLC - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.09%
자본화:
|
볼륨(24시간):